Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis

被引：20

作者：

Blank, Norbert ^{[1
]}

Max, Regina ^{[1
]}

Schiller, Martin ^{[1
]}

Briem, Steffen ^{[1
]}

Lorenz, Hanns-Martin ^{[1
]}

机构：

[1] Heidelberg Univ, Div Rheumatol, D-69120 Heidelberg, Germany

来源：

RHEUMATOLOGY | 2009年 / 48卷 / 04期

关键词：

B-CELL DEPLETION; DOUBLE-BLIND; EFFICACY; TRIAL;

D O I：

10.1093/rheumatology/ken491

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：440 / 441

页数：2

共 10 条

[1]

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks [J].

Cohen, Stanley B. ;

Emery, Paul ;

Greenwald, Maria W. ;

Dougados, Maxime ;

Furie, Richard A. ;

Genovese, Mark C. ;

Keystone, Edward C. ;

Loveless, James E. ;

Burmester, Gerd-Ruediger ;

Cravets, Matthew W. ;

Hessey, Eva W. ;

Shaw, Timothy ;

Totoritis, Mark C. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2793-2806

[2]

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].

Edwards, JCW ;

Szczepanski, L ;

Szechinski, J ;

Filipowicz-Sosnowska, A ;

Emery, P ;

Close, DR ;

Stevens, RM ;

Shaw, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581

[3]

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial [J].

Emery, P ;

Fleischmann, R ;

Filipowicz-Sosnowska, A ;

Schechtman, J ;

Szczepanski, L ;

Kavanaugh, A ;

Racewicz, AJ ;

Van Vollenhoven, RF ;

Li, NF ;

Agarwal, S ;

Hessey, EW ;

Shaw, TM .

ARTHRITIS AND RHEUMATISM, 2006, 54 (05) :1390-1400

[4]

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents [J].

Finckh, Axel ;

Ciurea, Adrian ;

Brulhart, Laure ;

Kyburz, Diego ;

Moeller, Burkhard ;

Dehler, Silvia ;

Revaz, Sylvie ;

Dudler, Jean ;

Gabay, Cem .

ARTHRITIS AND RHEUMATISM, 2007, 56 (05) :1417-1423

[5]

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate [J].

Genovese, MC ;

Cohen, S ;

Moreland, L ;

Lium, D ;

Robbins, S ;

Newmark, R ;

Bekker, P .

ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1412-1419

[6]

Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results [J].

Kavanaugh, A. ;

Rosengren, S. ;

Lee, S. J. ;

Hammaker, D. ;

Firestein, G. S. ;

Kalunian, K. ;

Wei, N. ;

Boyle, D. L. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) :402-408

[7]

Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis [J].

Leandro, MJ ;

Cambridge, G ;

Ehrenstein, MR ;

Edwards, JCW .

ARTHRITIS AND RHEUMATISM, 2006, 54 (02) :613-620

[8]

Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis [J].

Roll, Petra ;

Palanichamy, Arumugam ;

Kneitz, Christian ;

Dorner, Thomas ;

Tony, Hans-Peter .

ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2377-2386

[9]

Consensus statement on the use of rituximab in patients with rheumatoid arthritis [J].

Smolen, J. S. ;

Keystone, E. C. ;

Emery, P. ;

Breedveld, F. C. ;

Betteridge, N. ;

Burmester, G. R. ;

Dougados, M. ;

Ferraccioli, G. ;

Jaeger, U. ;

Klareskog, L. ;

Kvien, T. K. ;

Martin-Mola, E. ;

Pavelka, K. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) :143-150

[10]

Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial [J].

Weinblatt, Michael ;

Schiff, Michael ;

Goldman, Allan ;

Kremer, Joel ;

Luggen, Michael ;

Li, Tracy ;

Chen, Dalei ;

Becker, Jean-Claude .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) :228-234

← 1 →